258 Interestingly, studies have demonstrated that some probiotics can also significantly improve intestinal inflammation symptoms through the PI3K/AKT signaling pathway
Plant Polyphenols and Exendin-4 Prevent Hyperactivity and TNF- Release in LPS-Treated In vitro Neuron/Astrocyte/Microglial Networks
They are commonly used in provider-guided wellness protocols designed to support balanced eating habits, nutrient utilization, and overall metabolic efficiency
Robert Popovian, in Washington, D.C
Who Might Benefit Zepbound may be the strongest option for Hashimoto's patients who: Have a BMI of 30 or greater, or 27 or greater with at least one weight-related condition Haven't achieved meaningful weight loss with other medications or lifestyle interventions Have significant insulin resistance or prediabetes alongside their Hashimoto's Carry improved inflammatory markers (hsCRP above 3.0 mg/L) Want the maximum weight loss potential currently available in a single medication Don't have a history of medullary thyroid cancer or MEN2 Zepbound is FDA-approved for chronic weight management, so Hashimoto's patients who meet the BMI criteria have a recognized pathway to treatment
its about the quality of care, the level of personalization, and the long-term strategy